Literature DB >> 32105163

Investigating the prevalence and impact of device-related problems associated with hearing aid use.

Rebecca J Bennett1,2, Erin M Kosovich2, Inge Stegeman3,4, Azadeh Ebrahimi-Madiseh1,2, Susan Tegg-Quinn1,2, Robert H Eikelboom1,2,5.   

Abstract

Objective: To explore the prevalence of device-related problems associated with hearing aid use, participants' help-seeking behaviours for these problems, and factors associated with hearing aid problems.Design: A prospective convenience cohort design surveying 413 adult hearing aid users (34-97 years of age) recruited from seven clinics across Australia.
Results: Almost all participants (98%) indicated that they were experiencing at least one of the hearing aid problems included on the survey. The number of hearing aid related problems reported by participants ranged from 0 to 25 (of a possible 26), with a mean of 10 problems (SD = 5). The three most reported problems were related to difficulty hearing in noisy environments, hearing in windy environments, and understanding certain voices. Participants had reported less than half (46.33%) of the total problems identified to their clinic (range = 0-100%, mean = 43.40, SD = 13.92). Participants who reported experiencing a greater number of hearing aid problems also reported lower levels of hearing aid benefit, and satisfaction with their hearing aids.Conclusions: The majority of hearing aid owners experience problems with their hearing aids. Addressing these problems would likely contribute to improved hearing aid outcomes.

Entities:  

Keywords:  Hearing loss; audiologist; hearing aid; hearing aid issues; hearing aid management; hearing aid outcomes; hearing aid problems; survey

Mesh:

Year:  2020        PMID: 32105163     DOI: 10.1080/14992027.2020.1731615

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  1 in total

1.  Cochlear Implant Awareness: Development and Validation of a Patient Reported Outcome Measure.

Authors:  Laura M Markodimitraki; Inge Stegeman; Hans G X M Thomeer
Journal:  Front Neurosci       Date:  2022-04-29       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.